HUMAN IMMUNODEFICIENCY VIRUS
Clinical trials for HUMAN IMMUNODEFICIENCY VIRUS explained in plain language.
Never miss a new study
Get alerted when new HUMAN IMMUNODEFICIENCY VIRUS trials appear
Sign up with your email to follow new studies for HUMAN IMMUNODEFICIENCY VIRUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
HIV antibody monotherapy trial seeks virus suppression without daily pills
Disease control TerminatedThis study tested whether a monoclonal antibody called PRO 140 could keep HIV under control when used alone, replacing standard combination antiretroviral therapy (ART). Twenty adults with HIV who had completed a prior study without virus rebound were enrolled. The main goal was …
Matched conditions: HUMAN IMMUNODEFICIENCY VIRUS
Phase: PHASE2 • Sponsor: CytoDyn, Inc. • Aim: Disease control
Last updated May 17, 2026 00:31 UTC
-
HIV drug combo fails to trim fat in early trial
Disease control TerminatedThis study tested whether switching to a two-drug combination (raltegravir plus maraviroc) could reduce belly fat in people with well-controlled HIV. It included 48 adults who had been on stable HIV therapy for years and had excess belly fat. The trial was stopped early, so the r…
Matched conditions: HUMAN IMMUNODEFICIENCY VIRUS
Phase: PHASE2 • Sponsor: ANRS, Emerging Infectious Diseases • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
Program to boost HIV med adherence in virginia falls short
Disease control TerminatedThis study tested a program to help people with HIV in Virginia fill their antiretroviral prescriptions on time. The goal was to see if the program could improve viral suppression, meaning lower levels of HIV in the blood. Only 4 people enrolled before the study was stopped early…
Matched conditions: HUMAN IMMUNODEFICIENCY VIRUS
Phase: NA • Sponsor: Virginia Commonwealth University • Aim: Disease control
Last updated Apr 26, 2026 20:00 UTC